5% (95% CI: 3.0-17.2%, I2=95.8); North America: 6.5% (95% CI: 2.6-15.2%, I2=95.1); Europe: 16.5% (95% selleck kinase inhibitor CI: 9.5-27.0%, I2=92.0); Asia: 11.2% (95% CI: 3.6-29.7%, I2=96.8). While few studies were representative of the overall NIDU population, almost all provided detailed accounts of participant selection, data collection and possible confounders such as other transmission risks. Conclusions: Studies identified in this review found wide variability in the global prevalence of HCV infection among

NIDU. Even after subgroup analysis, heterogeneity within regional estimates was high due to the limited representativeness of study populations within each region. The estimates presented suggest that the burden of HCV infection is high among NIDU and efforts should be made to improve risk-based screening and prevent further transmission. Disclosures: The following people have nothing to disclose: Rebecca L. Morgan, Natalie Blackburn, Anthony K. Yartel, Don C. Des Jarlais Cholesterol metabolism can influence the natural history of HCV infection and antiviral response. ABCA1 is a key gatekeeper influencing intracellular cholesterol transport. Aims: to study the influence of ABCA1 SNPs rs2230806 and rs2230808 in patients with chronic hepatitis

C and potencial clinical impact. Methods: 295 Chronic HCV patients, 187 male (43.66±10.51 years), 108 female (49.49±13.39 years). HCV-RNA and genotype were determined by PCR. Liver steatosis, grading and staging were assessed by liver biopsy (Peter Scheuer score); ALT, γGT, lipid profile (LDL, HDL, total (t) cholesterol and tri-glycerides) quantified by standard

techniques. Exclusion criteria: other chronic liver diseases, alcohol ingestion Metabolism inhibitor >40g/ day, HIV infection, metabolic, cardiovascular and autoimmune diseases. ABCA1 SNPs rs2230806, rs2230808 were analyzed by melting-curves analysis in LightCycler480II. SNPs, clinical and histological parameters were compared in male and female. Statistical analysis by SPSS 21 (p<0.05). check details Results: The significant different parameters between gender/SNPs were tcholesterol, ALT, γGT, HCV-RNA and grading (see table). These parameters were related with liver histology (ste-atosis, grading and staging) and response to antiviral therapy. In male a significant correlation was found between: higher γGT / higher fibrosis (p=0.008) and non response to antiviral treatment (p=0.020); lower tcholesterol / higher steatosis (p<0.001) and grading (p=0.023). In female a significant correlation was found between: higher ALT / higher fibrosis (p=0.011), grading (p=0.006) and steatosis (p=0.050). Conclusion: ABCA1 genetic polymorphisms rs2230806 and rs2230808 are gender specific in chronic HCV patients, modulating cholesterol metabolism and histological severity. *OR (GG+GA)= 9.125 [1,646-50,595]; **OR (GG+GA)= 5.639 [1,344-23,652]; ***OR (GG)= 6.111 [1,414-26,408] Disclosures: The following people have nothing to disclose: Joana Ferreira, Cilénia B. Costa, Ricardo Andrade, Manuel Bicho, Fatima S.